Abdallah from Oman

Registered at the short selling broker Capital, 4 minutes ago.

» Try Capital you too
71.2% of retail investor accounts lose money when trading CFDs with Capital.
Don't show again

Sana Biotechnology Inc (SANA) shares information

Sana Biotechnology Inc


24h Change

3.47 %

SANA

Live rate: Market closed

Stock data per Wednesday 14 Apr, 2021

SANA
NASDAQ/NGS (GLOBAL SELECT MARKET)
24.2
24.5
25.04
0.84 (+ 3.47%)
US Market is closed

Live Stock price in graph for Sana Biotechnology Inc (SANA)

  • Latest Volume

    437,991 (2.11 %)

  • Volume prev. day

    428,926

  • Avg. daily volume

    493,839

  • Market cap

    4,695,146,659

  • P/E ratio

    n/a

  • Today high

    26.65 USD

  • Today low

    24.3 USD

  • 52 week high

    44.6 USD

  • 52 week low

    21.21 USD

  • YTD Change

    n/a

Quick links

 

Latest news about Sana Biotechnology Inc

Below you can find the most recent news posts about Sana Biotechnology Inc, primarily from US and UK based news sources.

The Daily Biotech Pulse: Fulgent's Big Quarter, Gilead Awaits FDA Decision, Apellis Winds Up COVID-19 Study

Friday, 5 March 2021, 14:15:09
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 4) AtriCure, Inc. (NASDAQ: ATRC ) Five Prime Therapeutics, Inc. ( NASDAQ: FPRX) – announced a deal to be bought by Amgen Inc. (NASDAQ: AMGN ) for $1.9 billion Down In The Dumps (Biotech Stocks Hitting 52-week Lows March 4) AbCellera Biologics Inc. (NASDAQ: ABCL ) Acutus Medical, Inc. (NASDAQ: AFIB ) ADC Therapeutics SA (NYSE: ADCT ) Aptose Biosciences Inc. (NASDAQ: APTO ) Assembly Biosciences, Inc. (NASDAQ: ASMB ) Athenex, Inc. (NASDAQ: ATNX ) Biophytis SA (NASDAQ: BPTS ) Bioventus Inc. (NASDAQ: BVS ) Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI ) BriaCell Therapeutics Corp. (NASDAQ: BCTX ) Decibel Therapeutics, Inc. (NASDAQ: DBTX ) Dyne Therapeutics, Inc. (NASDAQ: DYN ) (reacted to fourth-quarter results) Epizyme, Inc. (NASDAQ: EPZM ) Freeline Therapeutics Holdings plc (NASDAQ: FRLN ) Galecto, Inc. (NASDAQ: GLTO ) Inhibikase Therapeutics, Inc.
— Benzinga


How SPACs are changing the IPO game: Equity ownership of founders a big consideration

Tuesday, 2 March 2021, 17:58:00
A few weeks ago, a longtime GeekWire reader sent a note expressing shock that Sana Biotechnology co-founder and CEO Steve Harr only owned 4.9%
— GeekWire


The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO

Wednesday, 24 February 2021, 13:30:10
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 23) AxoGen, Inc (NASDAQ: AXGN ) (reacted to its fourth-quarter results) Gemini Therapeutics Inc (NASDAQ: GMTX ) Orthofix Medical Inc (NASDAQ: OFIX ) Solid Biosciences Inc (NASDAQ: SLDB ) Vascular Biogenics Ltd (NASDAQ: VBLT ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Feb. 23) AbCellera Biologics Inc (NASDAQ: ABCL ) Acutus Medical Inc (NASDAQ: AFIB ) Bioventus (NASDAQ: BVS ) bluebird bio Inc (NASDAQ: BLUE ) Evaxion Biotech A/S – ADR (NASDAQ: EVAX ) Imara Inc (NASDAQ: IMRA ) Kinnate Biopharma Inc (NASDAQ: KNTE ) Neurobo Pharmaceuticals Inc (NASDAQ: NRBO ) Pharming Group (NASDAQ: PHAR ) Sana Biotechnology Inc (NASDAQ: SANA ) Sarepta Therapeutics Inc (NASDAQ: SRPT ) Talis Biomedical Corp (NASDAQ: TLIS ) Vallon Pharmaceuticals Inc (NASDAQ: VLON ) Virpax Pharmaceuticals Inc (NASDAQ: VRPX ) Voyager Therapeutics Inc (NASDAQ: VYGR ) Stocks In Focus Bausch Health Agrees to Induct Icahn Group Nominees to its Board Bausch Health Companies Inc (NYSE: BHC ) said it will expand its board to add two designees from Carl Icahn and affiliated entities.
— Benzinga


The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts

Thursday, 11 February 2021, 13:26:22
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 11) 10X Genomics Inc (NASDAQ: TXG ) 9 Meters Biopharma Inc (NASDAQ: NMTR ) Abbott Laboratories (NYSE: ABT ) Acasti Pharma Inc (NASDAQ: ACST ) (reacted to its quarterly results) Advaxis, Inc. (NASDAQ: ADXS ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Alimera Sciences Inc (NASDAQ: ALIM ) Alkermes Plc (NASDAQ: ALKS ) Allakos Inc (NASDAQ: ALLK ) Anchiano Therapeutics Ltd – ADR (NASDAQ: ANCN AngioDynamics, Inc. (NASDAQ: ANGO ) Applied Molecular Transport Inc. (NASDAQ: AMTI ) Apyx Medical Corp (NASDAQ: APYX ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Artelo Biosciences Inc (NASDAQ: ARTL ) Aslan Pharmaceuticals Ltd (NASDAQ: ASLN ) AtriCure Inc. (NASDAQ: ATRC ) Avanos Medical Inc (NYSE: AVNS ) Beigene Ltd (NASDAQ: BGNE ) Bio-Path Holdings Inc (NASDAQ: BPTH ) (announced receipt of third patent related to manufacture of platform technology) Bolt Biotherapeutics Inc (NASDAQ: BOLT ) C4 Therapeutics Inc (NASDAQ: CCCC ) Cancer Genetics Inc (NASDAQ: CGIX ) (reacted to an update to merger terms with StemoniX) Cara Therapeutics Inc (NASDAQ: CARA ) Celcuity Inc (NASDAQ: CELC ) Cellular Biomedicine Group Inc (NASDAQ: CBMG ) Clearpoint Neuro Inc (NASDAQ: CLPT ) Clearside Biomedical Inc (NASDAQ: CLSD ) Collegium Pharmaceutical Inc (NASDAQ: COLL ) Collplant Biotechnologies Ltd – ADR (NASDAQ: CLGN ) Edap Tms SA (NASDAQ: EDAP ) Evogene Ltd (NASDAQ: EVGN ) Eyenovia Inc (NASDAQ: EYEN ) G1 Therapeutics Inc (NASDAQ: GTHX ) Gamida Cell Ltd (NASDAQ: GMDA ) ( reacted to a positive late-stags readout) Genetron Holdings Ltd – ADR (NASDAQ: GTH ) Glaukos Corp (NYSE: GKOS ) Guardion Health Sciences Inc (NASDAQ: GHSI ) Ideaya Biosciences Inc (NASDAQ: IDYA ) Illumina, Inc.
— Benzinga


Sana Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares – Stocks News Feed

Monday, 8 February 2021, 23:23:48
SEATTLE, Feb. 08, 2021 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ:SANA), a company focused on creating and delivering engineered cells as medicines, today announced the closing of its upsized initial public offering of 27,025,000 shares of its common stock at a public offering price of $25.00 per share, which includes the full exercise by the… Read More »Sana Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
— Stocks News Feed


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have SANA available or trade one of the many other CFD stocks they have.
Risk warning: 71.2% of retail investor accounts lose money when trading CFDs with Capital.